Restricted accessReplyFirst published online 2019-2
Reply to Letter by Seibold regarding Monika Reddy,Narvada Jugnee,Sinthuka Anantharaja,and Nick Oliver,Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
SeiboldA: Regarding: Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with type 1 diabetes at high hypoglycemia risk: the extension phase of the I HART CGM study—Concerns that reduce confidence in conclusions regarding hypoglycemia. Diabetes Technol Ther, 2019; 21:97–98.
2.
ReddyM, JugneeN, AnantharajaS, OliverN: Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with type 1 diabetes at high hypoglycemia risk: the extension phase of the I HART CGM study. Diabetes Technol Ther, 2018; 20:751–757.
OliverN, ReddyM: Reply to Seibold and Schlaeger iHART: methodological inconsistency precludes hypoglycaemia conclusions. Diabet Med, 2018; 35:1619–1620.
5.
ReddyM, JugneeN, SpanudakisE, et al.: A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med, 2018; 35:483–490.
6.
BaileyT, BodeBW, ChristiansenMP, et al.: The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther, 2015; 17:787–794.
7.
BaileyT, ChangA, ChristiansenMP, et al.: Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol, 2015; 9:209–214.
8.
PleusS, HeinemannL, FreckmannG: Blood glucose monitoring data should be reported in detail when studies about efficacy of continuous glucose monitoring systems are published. J Diabetes Sci Technol, 2018; 12:1061–1063.
9.
BolinderJ, AntunaR, Geelhoed-duijvestijnP, et al.: Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet, 2016; 388:2254–2263.
